Search results
- In Ontario, Quebec, and the Atlantic provinces, THCDs do not fall under the jurisdiction of the public cancer agency budget; patients have no choice but to rely on private plans, out-of-pocket (OOP) cash payments, provincial drug programs (if eligible), or compassionate programs provided by pharmaceutical manufacturers when a drug is not covered by programs available to the patient.
cdn.cancer.ca/-/media/files/about-us/media-releases/2022/thcd-report/uncovering-the-hidden-costs-of-take-home-cancer-drugs_08-11-21-2.pdf?rev=822dfd734dea497a94b0ca3dcf6db8dd&hash=3AA30A8EA7878E242DAEB0107C3D623C
People also ask
Can patients fill the funding gap for take-home cancer drugs in Ontario?
How much do take-home cancer drugs cost in Ontario?
Are fewer uninsured patients accessing take-home cancer drugs in Ontario?
Does Ontario cover take-home cancer drugs?
Jan 18, 2022 · CCS’s new report estimates that about 20% fewer uninsured patients are accessing take-home cancer medications in Ontario compared to patients with comprehensive public coverage. Currently, coverage eligibility for take-home cancer drugs varies significantly across Canadian provinces.
Jan 25, 2022 · A new report funded by the Canadian Cancer Society (CCS) is renewing calls from patient organizations to fill the funding gap for take-home cancer drugs in Ontario.
Dec 7, 2021 · The whitepaper identifies the gaps in access to Take Home Cancer Drugs (THCDs) in the provinces of Ontario, Nova Scotia, and New Brunswick. Using a model-based design, PDCI measured patient financial gaps in coverage and utilization for specified oral oncology drugs in the selected provinces.
Ontario's health system provided funding for 89 cancer medicines in the 2012–13 fiscal year and 167 cancer medicines (98 [59%] oral or take-home and 69 [41%] intravenous) in the 2021–22 fiscal year.
gaps in access to Take Home Cancer Drugs (THCDs) in select provinces. Using a model-based design, PDCI measured patient financial gaps in coverage and utilization for specified oral oncology drugs in the provinces of Ontario, Nova Scotia, and New Brunswick.
Feb 28, 2024 · The Canadian Cancer Society is urging Ontario to cover the costs of take-home cancer medications in the same way it does those that are administered in hospital.
A. Close the Unfair THCD Funding Gap for all Cancer Patients: Update Ontario’s cancer drug coverage model and implement an estimated ~$30M (net pharmaceutical discounts) budget increase of close-the-gap funding for THCDs for those younger than 65 who are uninsured and underinsured (~10,000 people/year).
